Search

Your search keyword '"Barrios C."' showing total 1,310 results

Search Constraints

Start Over You searched for: Author "Barrios C." Remove constraint Author: "Barrios C."
1,310 results on '"Barrios C."'

Search Results

251. Heteroepitaxy of InP on Silicon-on-Insulator for Optoelectronic Integration

252. Heteroepitaxy and selective epitaxy for discrete and integrated devices

253. Reconciling Introspective Utility with Revealed Preference: Experimental Arguments Based on Prospect Theory

257. La fijación externa monolateral en el tratamiento de las fracturas femorales del niño: experiencia preliminar en 20 casos

258. Abstract OT2-2-03: Dovitinib (TKI258) or placebo in combination with fulvestrant in postmenopausal, endocrine-resistant HER2–/HR+ breast cancer: a phase II study

260. PCN21 Melody Brasil: Real World Health Outcomes of the Treatment of Metastatic Melanoma Patients in the Brazilian Health System

262. Efficacy and Patient (PT)-Reported Outcomes (PROS) aith Selumetinib (AZD6244, ARRY-142866; SEL) + Docetaxel (DOC) in Kras-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC): A Randomized, Phase II Trial

265. Cardiovascular complications in CKD 5D

268. Aspectos epidemiológicos del traumatismo múltiple en un hospital de referencia: experiencia de 1 año

271. Transplantation: clinical studies

272. A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE).

273. A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC).

274. A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).

275. Anti-LeY monoclonal antibody (mAb) hu3S193 (Rebmab 100) in patients with advanced platinum resistant/refractory (PRR) ovarian cancer (OC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC).

286. Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen

288. Abstract P5-10-15: First Safety Data from a Randomised Phase III (CIBOMA 2004- 01/GEICAM 2003-11) Trial Assessing Adjuvant Capecitabine Maintenance Therapy after Standard Chemotherapy for Triple-Negative Early Breast Cancer

292. Microfluidic and transducer technologies for lab on a chip applications

294. Efficacy and safety of PF299804 versus erlotinib (E): A global, randomized phase II trial in patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of chemotherapy (CT).

297. 101 STRIDE: phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer

298. A packaged optical slot-waveguide ring resonator sensor array for multiplex label-free assays in labs-on-chips

299. Time-resolved micro-photoluminescence studies of deep level distribution in selectively regrown GaInP : Fe and GaAs : Fe

300. Time-resolved micro-photoluminescence studies of dopant distribution in selectively regrown GalnP : Fe around VCSELs

Catalog

Books, media, physical & digital resources